Reuters logo
BRIEF-Vanc Pharmaceuticals receives Health Canada class-III approval for ferrous fumarate products
2017年9月8日 / 晚上7点15分 / 18 天前

BRIEF-Vanc Pharmaceuticals receives Health Canada class-III approval for ferrous fumarate products

Sept 8 (Reuters) - Vanc Pharmaceuticals Inc

* Vanc pharmaceuticals receives health canada class-iii approval for ferrous fumarate products

* Vanc pharmaceuticals inc - ‍has received health canada class-iii approval of ferrous fumarate tablets and capsules for use in iron deficiency anemia​

* Vanc pharmaceuticals inc - that it will not be proceeding with 2nd tranche closing of non-brokered private placement announced july 20, 2017​

* Vanc pharmaceuticals inc - ‍plans to secure additional financing in due course​ Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below